VIVO BIO TECH LTD.
₹13.68▼ -0.17 (-1.23%)
VIVOBIOT·BSE·Healthcare
Market Cap
30.25 Cr
PE Ratio
-13.20
Volume
3,051
Day High - Low
14.43 - 13.67
52W High-Low
20.94 - 12.80
₹13.68▼ -0.17 (-1.23%)
Market Cap30.25 Cr
PE Ratio-13.20
Volume3,051
Day High - Low14.43 - 13.67
52W High-Low20.94 - 12.80
Vivo Bio Tech Ltd. (VIVOBIOT): company summary
The company's annual revenue rose 14.3% to ₹53 crore, but net profit swung to a loss of ₹2 crore from a profit of ₹7 crore.
Vivo Bio Tech Ltd. (VIVOBIOT) is a micro-cap Healthcare company valued at ₹30 crore operating in Biotechnology on the NSE and BSE.
- Recent price move
- Vivo Bio Tech Ltd. last traded at ₹13.68, modestly down 1.23% on the day.
- Recent developments
- On 2026-06-30, the company reported a net loss of ₹2 crore for the fiscal year ending March 2026, marking a sharp decline from a profit of ₹7 crore in the previous year. In the latest quarter, net profit dropped to ₹0 crore from ₹1 crore in the same quarter a year earlier, despite a 14.1% rise in revenue. Promoter holding fell by 4.81 percentage points to 30.62% as of June 2026.
- Financial performance
- The company's annual revenue rose 14.3% to ₹53 crore, but net profit swung to a loss of ₹2 crore from a profit of ₹7 crore. In the latest quarter, revenue increased 14.1% to ₹14 crore, but net profit fell 85.8% to ₹0 crore from ₹1 crore in the same quarter a year earlier. The net profit margin deteriorated to -3.2% from 15.6% a year ago, and return on equity turned negative to -1.8%.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 0.41 times book value.
- Things to watch
- The company reported a net loss of ₹2 crore in the latest fiscal year, compared to a profit of ₹7 crore in the prior year. Net profit margin fell to -3.2%, a 18.8 percentage point decline from 15.6% a year ago. Promoter holding decreased by 4.81 percentage points, signaling potential dilution of control.
- Where it stands
- The company ended the fiscal year with a net loss of ₹2 crore, while revenue grew 14.3% to ₹53 crore. The latest quarter saw revenue rise 14.1% to ₹14 crore, but net profit fell to ₹0 crore from ₹1 crore a year earlier. The most significant movement was the net profit margin dropping to -3.2%.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
4.3/10
Weak
Fair Value
Sign in to see
ROE
-1.83%
Weak
P/E
-13.20x
Loss-making
Debt / Equity
0.72
Moderate
Industry
Healthcare
Biotechnology
Overall View
Weak
Price performance
Day₹13.67
₹14.43
52W₹12.80
₹20.94
DocStoX take
Supported by risk (6.2) and valuation (6.0), but held back by momentum (0.0).
DocStoX score
Low confidence4.3
/10
Weak
Quality
Modest
ROE -1.8%
Valuation
Fair
P/B 0.4× on assets (no earnings to value)
Growth
Slow
Revenue +0.6% 5Y CAGR
Risk
Moderate
D/E 0.72
Momentum
Weak
11% of 52-week range
At a glance
Market Cap
₹30 Cr
52W High / Low
₹21 / ₹13
Dividend Yield
0.00%
Promoter Holding
30.62%
EPS (TTM)
₹-0.82
Book Value
₹41.98
Key highlights
- Loss-making — no meaningful P/E
- Momentum is weak (0.0/10)
0 Positives4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Biotechnology
Explore VIVO BIO TECH LTD.’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
VIVO BIO TECH LTD. peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LLAURUS LABS LIMITEDZYDUS LIFESCIENCES LTDAPOLLO HOSPITALS ENTER. LCIPLA LTDDR. REDDY S LABORATORIESAUROBINDO PHARMA LTDMANKIND PHARMA LIMITEDLUPIN LIMITEDMANIPAL HEALTH ENTERPRI L
Compare VIVO BIO TECH LTD. with peers
Related tools & concepts
Value VIVO BIO TECH LTD. with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing